EP0881907A4 - Agents cycliques peptidiques antifongiques - Google Patents

Agents cycliques peptidiques antifongiques

Info

Publication number
EP0881907A4
EP0881907A4 EP97904148A EP97904148A EP0881907A4 EP 0881907 A4 EP0881907 A4 EP 0881907A4 EP 97904148 A EP97904148 A EP 97904148A EP 97904148 A EP97904148 A EP 97904148A EP 0881907 A4 EP0881907 A4 EP 0881907A4
Authority
EP
European Patent Office
Prior art keywords
antifungal agents
cyclic peptide
peptide antifungal
cyclic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97904148A
Other languages
German (de)
English (en)
Other versions
EP0881907A1 (fr
Inventor
Stacy K Henle
William W Turner Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603151.3A external-priority patent/GB9603151D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0881907A1 publication Critical patent/EP0881907A1/fr
Publication of EP0881907A4 publication Critical patent/EP0881907A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97904148A 1996-02-01 1997-01-29 Agents cycliques peptidiques antifongiques Withdrawn EP0881907A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1094696P 1996-02-01 1996-02-01
US10946P 1996-02-01
GBGB9603151.3A GB9603151D0 (en) 1996-02-15 1996-02-15 Cyclic peptide antifungal agents
GB9603151 1996-02-15
PCT/US1997/001607 WO1997027864A1 (fr) 1996-02-01 1997-01-29 Agents cycliques peptidiques antifongiques

Publications (2)

Publication Number Publication Date
EP0881907A1 EP0881907A1 (fr) 1998-12-09
EP0881907A4 true EP0881907A4 (fr) 2000-05-10

Family

ID=26308710

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97904148A Withdrawn EP0881907A4 (fr) 1996-02-01 1997-01-29 Agents cycliques peptidiques antifongiques

Country Status (5)

Country Link
EP (1) EP0881907A4 (fr)
JP (1) JP2001503015A (fr)
AU (1) AU1851797A (fr)
CA (1) CA2244238A1 (fr)
WO (1) WO1997027864A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323176B1 (en) * 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (fr) 1998-08-20 2005-01-26 Eli Lilly & Company Synthese des analogues peptidiques cycliques a systeme cyclique modifie
WO2000034315A2 (fr) 1998-12-09 2000-06-15 Eli Lilly And Company Purification de composes cyclopeptidiques d'echinocandine
AU772633B2 (en) 1999-03-03 2004-05-06 Eli Lilly And Company Echinocandin/carbohydrate complexes
BR0008713A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Processos para preparar formulações ecomposições farmacêuticas orais com ecb
ES2433678T3 (es) 1999-03-03 2013-12-12 Eli Lilly & Company Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas
EP1155034B1 (fr) * 1999-03-03 2006-08-30 Eli Lilly And Company Formation et echange d'anions de sels internes cristallins d'ammonium echinocandine b
WO2004035563A1 (fr) * 2002-10-17 2004-04-29 Syngenta Participations Ag Derives de 3-heterocyclylpyridine utilises comme herbicides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0736541A1 (fr) * 1995-04-07 1996-10-09 Eli Lilly And Company Hexapeptides cycliques ayant une activité antifongique
EP0744405A2 (fr) * 1995-05-26 1996-11-27 Eli Lilly And Company Peptides cycliques ayant une activité antifongique
WO1998023637A1 (fr) * 1996-11-25 1998-06-04 Fujisawa Pharmaceutical Co., Ltd. Cyclohexapeptides ayant une activite antimicrobienne

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0736541A1 (fr) * 1995-04-07 1996-10-09 Eli Lilly And Company Hexapeptides cycliques ayant une activité antifongique
EP0744405A2 (fr) * 1995-05-26 1996-11-27 Eli Lilly And Company Peptides cycliques ayant une activité antifongique
WO1998023637A1 (fr) * 1996-11-25 1998-06-04 Fujisawa Pharmaceutical Co., Ltd. Cyclohexapeptides ayant une activite antimicrobienne

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9727864A1 *

Also Published As

Publication number Publication date
AU1851797A (en) 1997-08-22
WO1997027864A1 (fr) 1997-08-07
JP2001503015A (ja) 2001-03-06
CA2244238A1 (fr) 1997-08-07
EP0881907A1 (fr) 1998-12-09

Similar Documents

Publication Publication Date Title
AU8687798A (en) Cyclic peptide antifungal agents
IL118334A0 (en) Cyclic peptide antifungal agents
HUP9800809A3 (en) Cyclic peptide antifungal agents
IL118331A0 (en) Cyclic peptide antifungal agents
EP0765165A4 (fr) Peptides empeches
AU2686099A (en) Cyclic peptide antifungal agents
PL318017A1 (en) Peptides
GB9718110D0 (en) Peptides
EP0881907A4 (fr) Agents cycliques peptidiques antifongiques
EP1040120A4 (fr) Peptides antifongiques et antibacteriens
GB9700154D0 (en) Peptides
GB9425380D0 (en) Peptides
GB9812675D0 (en) Peptides
ZA9711392B (en) Cyclic peptide derivatives
EP0996457A4 (fr) Peptides liberateurs de f.s.h.
GB9603151D0 (en) Cyclic peptide antifungal agents
GB9807890D0 (en) Peptides
GB9613705D0 (en) Novel peptides
GB9425381D0 (en) Peptides
GB9606552D0 (en) Antifungal proteins
AU6408499A (en) Cyclic peptides as antifungal agents
GB9605904D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9612648D0 (en) Peptides
GB9608430D0 (en) Peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000324

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/12 A, 7C 07K 5/00 B, 7C 07K 7/56 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050802